Use of aromatase inhibitors in patients with breast cancer is associated with deterioration of bone microarchitecture and density.
Arch Endocrinol Metab
; 65(4): 505-511, 2021 Nov 03.
Article
in En
| MEDLINE
| ID: mdl-34283901
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Osteoporosis
/
Breast Neoplasms
Type of study:
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Arch Endocrinol Metab
Year:
2021
Document type:
Article
Affiliation country:
Brazil